Deep Value Reports

CMPS Stock Risk & Deep Value Analysis

COMPASS Pathways plc

DVR Score

8.4

out of 10

Hidden Gem

The Bottom Line on CMPS

We analyzed COMPASS Pathways plc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran CMPS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Sep 5, 2025•Run Fresh Analysis →

CMPS Deep Value Analysis

COMPASS Pathways (CMPS) targets the immense, underserved market of treatment-resistant depression with its COMP360 psilocybin therapy. Its strong IP, first-mover advantage in Phase 3 trials, and recent capital raise for an extended runway are compelling. Major catalysts like Phase 3 results and potential FDA approval could drive significant re-rating and 10x growth within 3-5 years. While regulatory hurdles and commercialization challenges are substantial, the company's progress and strategic focus mitigate 'dud' concerns, positioning it as a high-potential, high-risk play in a transformative healthcare segment.

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More